静脉输注免疫球蛋白治疗特发性血小板减少性紫癜  

Treatment of Idiopathic Thrombocytopenic Purpura with Intravenous Ig (IVIg)

作　　者：宋艳秋[1] 姜振宇[1] 李舜华[1] 李薇[1] 高素君[1] 时亚香 王春艳[1] 易永林[1] 刘淑英[2] 聂荣国[2] 陈维金[2] 

机构地区：[1]白求恩医科大学第一临床医院,长春130021 [2]卫生部长春生物制品研究所

出　　处：《中国生物制品学杂志》1995年第3期126-128,共3页Chinese Journal of Biologicals

摘　　要：大剂量静脉输注免疫球蛋白（IVIg）治疗特发性血小板减少性紫癜（ITP）20例，15天之内100％病例血小板升至5×1010／L以上．70％病例血小板升至1×1011／L以上，与激素治疗组相比，具有血小板升速快，幅度大的优点。经激素治疗无效的患者，用大剂量IVIg治疗亦有效，使用中未发现毒副作用。20 cases of idiopathic thrombocytopenic purpura (ITP) were treated with in-travenous Ig (IVIg) in high dosage. Within 15 days, the platelet amounts of all case increasedup to ＞5 × 1010/L, and 70% of them increased up to＞1×1011/L. Compared with thosetreated with hormone, the platelet amounts of the patients treated with IVIg increased at ahigher speed and to a higher extent. The IVIg was demonstrated to be effective in the caseswho failed to respond to hormone, and no side effect was found during the administration.

关 键 词：紫癜 特发性 血小板感少性 免疫球蛋白 静脉输注 

分 类 号：R554.605[医药卫生—血液循环系统疾病]